Our Board

Professor Olver is a cancer researcher, medical oncologist and bioethicist, and is currently a Professor in the Faculty of Health and Medical Sciences at the University of Adelaide. His past positions include Director of the Royal Adelaide Hospital Cancer Centre, CEO of Cancer Council Australia, and Director of the University of South Australia Cancer Research Institute. He is past president of the Medical Oncology Group of Australia and the Multinational Association of Supportive Care in Cancer. He was appointed a Member of the Order of Australia in 2011 for services to medical oncology.

Ms Anderson has more than 30 years’ experience as a CEO and senior executive in a range of marketing and media companies, including Southern Star Entertainment, PBL, Ninemsn and Reading Room Inc (bookstr.com), of which she was CEO and founder. As well as her knowledge of the marketing, media and entertainment sectors, Ms Anderson is a former Fellow of the University of Sydney Senate, and serves on the Boards of ASX-listed companies including Carsales.com, Invocare, Siteminder, and in previous years Marley Spoon AG and WPP AUNZ.

Dr Kerry Chant is NSW Chief Health Officer and Deputy Secretary of the Population and Public Health Division, NSW Ministry of Health. The Division has accountabilities for a broad portfolio of issues, including tobacco control, reduction of risky drinking and obesity, the promotion of physical activity, end-of-life care and organ donation. Dr Chant has a particular interest in the response to HIV, hepatitis C and hepatitis B and Aboriginal health.

Ms Low is a distinguished chartered accountant and finance expert, who was with PwC Australia for more than 28 years. She sits on the boards of four ASX listed companies: Appen Limited, AUB Group Limited, IPH Limited and Marley Spoon AG and is a member of Australian Reinsurance Pool Corporation. She is a former deputy chair of the Audit and Assurance Standards Board, and sits on the boards of various not-for-profit organisations including Guide Dogs ACT/NSW, Public Education Foundation and Primary Ethics.

Professor Preen is the Chair in Public Health at the School of Population and Global Health, University of Western Australia (UWA) and was Director of the UWA Centre for Health Services Research from 2006-2015. He also holds honorary positions at the University of South Australia and Swansea University (UK). His current role is aimed at bridging the divide between academia and government to increase the translation of research findings to facilitate evidence-based decision making in policy settings.

Dr Studdert is Head of Office at the Australian Government’s Productivity Commission. Lisa was most recently Deputy CEO of the National Disability Insurance Agency (NDIA), and was previously a Deputy Secretary at the Federal Department of Health where she worked across a range of areas including population health, aged care, Indigenous health, and cancer screening.  She has extensive experience working in health programs internationally, including for the Asian Development Bank, United Nations agencies and for the Australian aid program including extended periods in Vietnam, Indonesia and Cambodia.

Professor Whiteman is a medical epidemiologist at the QIMR Berghofer Medical Research Institute in Brisbane, where he was deputy director from 2016–2021. He has a special interest in the causes, control and prevention of cancer and leads a program of research comprising national and international studies of melanoma and other cancers. He is a Fellow of the Australian Academy of Health and Medical Sciences, a Fellow of the Australasian Faculty of Public Health Medicine and a member of the Academy of the National Health and Medical Research Council of Australia.

Martin became the Institute’s CEO in January 2023, after serving as Deputy CEO since 2018. An experienced health system executive, he has previously held a number of senior leadership roles at Commonwealth and state levels, spanning strategy and research to policy development and health system performance. Since joining the Institute in 2016, Martin has guided the development of a number of the Institute’s key programs, and he remains Chief Investigator of the 45 and Up Study. Prior to joining the Institute, he was Executive Director at the National Health Performance Authority. Martin has a PhD from the University of Sydney.